CASP3 and neoplasm: Low tumour caspase-3 activity (⩽median) was also accompanied by a shorter time to recurrence compared to patients with a high tumour caspase-3 activity (Figure 2C), with 5-year recurrence rates of 46.1% and 30.3%, respectively.